OA12721A - Forme polymorphe du rimonabant, son procédé de préparation et les compositions pharmaceutiques en contenant. - Google Patents
Forme polymorphe du rimonabant, son procédé de préparation et les compositions pharmaceutiques en contenant. Download PDFInfo
- Publication number
- OA12721A OA12721A OA1200400131A OA1200400131A OA12721A OA 12721 A OA12721 A OA 12721A OA 1200400131 A OA1200400131 A OA 1200400131A OA 1200400131 A OA1200400131 A OA 1200400131A OA 12721 A OA12721 A OA 12721A
- Authority
- OA
- OAPI
- Prior art keywords
- temperature
- rimonabant
- methylcyclohexane
- medium
- concentration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0114579A FR2831883B1 (fr) | 2001-11-08 | 2001-11-08 | Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12721A true OA12721A (fr) | 2006-06-27 |
Family
ID=8869285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200400131A OA12721A (fr) | 2001-11-08 | 2002-11-04 | Forme polymorphe du rimonabant, son procédé de préparation et les compositions pharmaceutiques en contenant. |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20050043356A1 (es) |
| EP (1) | EP1446384A1 (es) |
| JP (2) | JP4181994B2 (es) |
| KR (2) | KR20090089485A (es) |
| CN (1) | CN100412063C (es) |
| AP (1) | AP1830A (es) |
| AR (1) | AR037253A1 (es) |
| AU (1) | AU2002350869B2 (es) |
| BR (1) | BR0213931A (es) |
| CA (1) | CA2464145A1 (es) |
| CO (1) | CO5580827A2 (es) |
| CR (1) | CR7333A (es) |
| EA (1) | EA006771B1 (es) |
| EC (1) | ECSP045088A (es) |
| FR (1) | FR2831883B1 (es) |
| GE (1) | GEP20063894B (es) |
| HR (1) | HRP20040403A2 (es) |
| HU (1) | HUP0402043A3 (es) |
| IL (2) | IL161533A0 (es) |
| IS (1) | IS7226A (es) |
| MA (1) | MA27080A1 (es) |
| ME (1) | MEP21908A (es) |
| MX (1) | MXPA04004394A (es) |
| NO (1) | NO326648B1 (es) |
| NZ (1) | NZ532369A (es) |
| OA (1) | OA12721A (es) |
| PL (1) | PL369372A1 (es) |
| RS (1) | RS36904A (es) |
| TN (1) | TNSN04079A1 (es) |
| TW (1) | TW200302824A (es) |
| UA (1) | UA76776C2 (es) |
| WO (1) | WO2003040105A1 (es) |
| ZA (1) | ZA200402999B (es) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2831883B1 (fr) * | 2001-11-08 | 2004-07-23 | Sanofi Synthelabo | Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| BR0312297A (pt) | 2002-07-18 | 2005-04-12 | Cytos Biotechnology Ag | Conjugados veìculos de hapteno e seu uso |
| FR2861992B1 (fr) * | 2003-11-10 | 2007-07-20 | Sanofi Synthelabo | Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide. |
| CA2613235A1 (en) | 2005-06-30 | 2007-01-11 | Prosidion Limited | Gpcr agonists |
| EP1816125A1 (en) * | 2006-02-02 | 2007-08-08 | Ranbaxy Laboratories, Ltd. | Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof |
| FR2897060B1 (fr) * | 2006-02-08 | 2008-07-25 | Sanofi Aventis Sa | Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| WO2008038143A2 (en) * | 2006-06-22 | 2008-04-03 | Medichem, S.A. | Novel solid forms of rimonabant and synthetic processes for their preparation |
| WO2008044153A2 (en) * | 2006-08-29 | 2008-04-17 | Medichem, S.A. | Improved method for synthesizing rimonabant |
| WO2008026219A2 (en) * | 2006-09-01 | 2008-03-06 | Hetero Drugs Limited | Novel polymorphs of rimonabant |
| EP2061783A2 (en) * | 2006-09-11 | 2009-05-27 | Hetero Drugs Limited | Improved process for rimonabant |
| WO2008035023A1 (en) * | 2006-09-19 | 2008-03-27 | Cipla Limited | Polymorphs of rimonabant |
| WO2008056377A2 (en) * | 2006-11-06 | 2008-05-15 | Cadila Healthcare Limited | Polymorphic forms of rimonabant |
| WO2008064615A2 (en) * | 2006-12-01 | 2008-06-05 | Zentiva, A.S. | Crystalline and amorphous forms of rimonabant and processes for obtaining them |
| MX2009006214A (es) * | 2006-12-18 | 2009-06-22 | 7Tm Pharma As | Moduladores del receptor cb1. |
| AR064736A1 (es) | 2007-01-04 | 2009-04-22 | Prosidion Ltd | Agonistas de gpcr |
| PT2114933E (pt) | 2007-01-04 | 2011-12-20 | Prosidion Ltd | Agonistas do gpcr de piperidina |
| AR064735A1 (es) | 2007-01-04 | 2009-04-22 | Prosidion Ltd | Agonistas de gpcr y composicion farmaceutica en base al compuesto |
| GB0700122D0 (en) | 2007-01-04 | 2007-02-14 | Prosidion Ltd | GPCR agonists |
| WO2008081208A1 (en) | 2007-01-04 | 2008-07-10 | Prosidion Limited | Piperidine gpcr agonists |
| EP1944297A1 (en) * | 2007-01-09 | 2008-07-16 | Miklós Vértessy | Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof |
| WO2008088900A2 (en) * | 2007-01-18 | 2008-07-24 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of rimonabant base and processes for preparation thereof |
| EP1953144A1 (en) | 2007-01-30 | 2008-08-06 | Sandoz AG | Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide |
| FR2919862A1 (fr) * | 2007-08-06 | 2009-02-13 | Sanofi Aventis Sa | Le solvate de 3-methylbutan-1-ol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| FR2919865A1 (fr) * | 2007-08-06 | 2009-02-13 | Sanofi Aventis Sa | Le solvate de dmso de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| FR2919867A1 (fr) * | 2007-08-06 | 2009-02-13 | Sanofi Aventis Sa | Le solvate de 2-methoxyethanol de rimonabant et son procede de preparation |
| FR2919864A1 (fr) * | 2007-08-06 | 2009-02-13 | Sanofi Aventis Sa | Le solvate de 1,4-dioxane de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| FR2919863A1 (fr) * | 2007-08-06 | 2009-02-13 | Sanofi Aventis Sa | Le solvate de n-methylpyrrolidone de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| GB0720389D0 (en) | 2007-10-18 | 2008-11-12 | Prosidion Ltd | G-Protein Coupled Receptor Agonists |
| GB0720390D0 (en) | 2007-10-18 | 2007-11-28 | Prosidion Ltd | G-Protein coupled receptor agonists |
| WO2009153804A1 (en) * | 2008-06-16 | 2009-12-23 | Cadila Healthcare Limited | Process for preparing form i of rimonabant |
| WO2010079241A1 (es) | 2009-01-12 | 2010-07-15 | Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion | Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas |
| FR3008620A1 (fr) * | 2013-07-22 | 2015-01-23 | Sanofi Sa | Formulation de comprime d'un inhibiteur de phosphatidylinositol 3-kinase |
| JPWO2021075494A1 (es) * | 2019-10-16 | 2021-04-22 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| US7109245B2 (en) * | 2001-08-15 | 2006-09-19 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Vasoconstrictor cannabinoid analogs |
| FR2831883B1 (fr) * | 2001-11-08 | 2004-07-23 | Sanofi Synthelabo | Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
-
2001
- 2001-11-08 FR FR0114579A patent/FR2831883B1/fr not_active Expired - Fee Related
-
2002
- 2002-04-11 UA UA20040402974A patent/UA76776C2/uk unknown
- 2002-11-04 JP JP2003542151A patent/JP4181994B2/ja not_active Expired - Fee Related
- 2002-11-04 KR KR1020097016373A patent/KR20090089485A/ko not_active Application Discontinuation
- 2002-11-04 AP APAP/P/2004/003024A patent/AP1830A/en active
- 2002-11-04 BR BR0213931-6A patent/BR0213931A/pt not_active IP Right Cessation
- 2002-11-04 CA CA002464145A patent/CA2464145A1/en not_active Abandoned
- 2002-11-04 KR KR1020047006969A patent/KR20050043774A/ko not_active Application Discontinuation
- 2002-11-04 EP EP02785580A patent/EP1446384A1/fr not_active Withdrawn
- 2002-11-04 PL PL02369372A patent/PL369372A1/xx not_active Application Discontinuation
- 2002-11-04 RS YU36904A patent/RS36904A/sr unknown
- 2002-11-04 US US10/494,211 patent/US20050043356A1/en not_active Abandoned
- 2002-11-04 AU AU2002350869A patent/AU2002350869B2/en not_active Ceased
- 2002-11-04 IL IL16153302A patent/IL161533A0/xx unknown
- 2002-11-04 OA OA1200400131A patent/OA12721A/fr unknown
- 2002-11-04 MX MXPA04004394A patent/MXPA04004394A/es unknown
- 2002-11-04 ME MEP-219/08A patent/MEP21908A/xx unknown
- 2002-11-04 CN CNB028219686A patent/CN100412063C/zh not_active Expired - Fee Related
- 2002-11-04 EA EA200400491A patent/EA006771B1/ru not_active IP Right Cessation
- 2002-11-04 WO PCT/FR2002/003765 patent/WO2003040105A1/fr active Application Filing
- 2002-11-04 HU HU0402043A patent/HUP0402043A3/hu unknown
- 2002-11-04 NZ NZ532369A patent/NZ532369A/en not_active IP Right Cessation
- 2002-11-04 GE GE5606A patent/GEP20063894B/en unknown
- 2002-11-06 AR ARP020104228A patent/AR037253A1/es unknown
- 2002-11-07 TW TW091132763A patent/TW200302824A/zh unknown
-
2004
- 2004-04-19 IS IS7226A patent/IS7226A/is unknown
- 2004-04-20 IL IL161533A patent/IL161533A/en not_active IP Right Cessation
- 2004-04-20 ZA ZA200402999A patent/ZA200402999B/en unknown
- 2004-04-27 EC EC2004005088A patent/ECSP045088A/es unknown
- 2004-04-28 MA MA27659A patent/MA27080A1/fr unknown
- 2004-05-04 CR CR7333A patent/CR7333A/es unknown
- 2004-05-04 CO CO04040840A patent/CO5580827A2/es not_active Application Discontinuation
- 2004-05-06 HR HR20040403A patent/HRP20040403A2/hr not_active Application Discontinuation
- 2004-05-07 NO NO20041879A patent/NO326648B1/no not_active IP Right Cessation
- 2004-05-07 TN TNP2004000079A patent/TNSN04079A1/fr unknown
-
2008
- 2008-07-11 JP JP2008181474A patent/JP4931874B2/ja not_active Expired - Fee Related
- 2008-10-28 US US12/259,701 patent/US20100190827A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA12721A (fr) | Forme polymorphe du rimonabant, son procédé de préparation et les compositions pharmaceutiques en contenant. | |
| EP0658546B1 (fr) | Dérivés de 3-pyrazolecarboxamide avec une affinité pour le récepteur des cannabinoides | |
| EP1230244B1 (fr) | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant | |
| EP1537087B1 (fr) | Derives de 3-aminoindazole comme inhibiteurs de kinase et compositions pharmaceutiques les renfermant | |
| EP0876350B1 (fr) | Derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| EP0656354B1 (fr) | N-pipéridino-3-pyrazolecarboxamide substitué | |
| FR2792314A1 (fr) | Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| WO2000046209A1 (fr) | Derives d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant | |
| FR2815030A1 (fr) | Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments | |
| FR2569694A1 (fr) | Derives d'ethylenediaminemonoamide, composition pharmaceutique les contenant et utilisation de ces composes a titre d'antidepresseur ou d'antiparkinsonien | |
| JPH11502230A (ja) | インダゾールカルボキサミド類 | |
| CA2767096A1 (fr) | Derives de pyrazoles, leur preparation et leur application en therapeutique | |
| CA2089349C (fr) | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP1102747B1 (fr) | Formes cristallines du osanetant | |
| WO1995001334A1 (fr) | Composes indoliques derives d'arylamines comme ligands selectifs des recepteurs 5ht1d et 5ht¿1b? | |
| CA2557942C (fr) | Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique | |
| FR2897060A1 (fr) | Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant | |
| EP1551821B1 (fr) | Derives de 3-(cyclopenten-1-yl)-benzyl- ou 3-(cyclopenten-1-yl)-heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie | |
| FR2897614A1 (fr) | Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations | |
| EP0728755A1 (fr) | Nouveaux composés du thiophène, leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
| FR2789078A1 (fr) | Derives d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant | |
| FR2713224A1 (fr) | N-pipéridino-3-pyrazolecarboxamide substitué. |